𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of Model for End-Stage Liver Disease in the Occurrence of Infectious Events and Survival in a Cohort of Liver Transplant Recipients

✍ Scribed by Clemente, W.T.; Romanelli, R.M.C.; Faria, L.C.; Lima, S.S.S.; Jesus, L.A.; Cortes, J.R.G.; Sanches, M.D.; Cançado, O.L.; Lima, A.S.

Book ID
121674344
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
446 KB
Volume
45
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The pediatric end-stage liver disease (P
The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients
✍ Neal R. Barshes; Timothy C. Lee; Ian W. Udell; Christine A. O'Mahoney; Saul J. K 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 1 views

The pediatric end-stage liver disease (PELD) model accurately estimates 90-day waitlist mortality for pediatric liver transplant candidates, but it has been unclear if PELD can identify patients who will derive survival benefit from undergoing liver transplantation (LT), if it correlates with posttr

Survival after liver transplantation for
Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre–model for end-stage liver disease eras and the independent impact of hepatitis C virus
✍ Paul J. Thuluvath; Anurag Maheshwari; Nimisha P. Thuluvath; Geoffrey C. Nguyen; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 1 views

It has been suggested that hepatitis C virus (HCV) patients with hepatocellular carcinoma (HCC) may have worse outcomes after liver transplantation (LT) because of more aggressive tumor biology. In this study, we determined the post-LT survival of HCC patients with and without HCV using United Netwo